Abnormal findings on antenatal screening of mother

O15_ANTENAT_ABNORM

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — O28 Hospital discharge: ICD-9 — 7923 Cause of death: ICD-10 — O28 Cause of death: ICD-9 — 7923 2 out of 7 registries used, show all original rules.	3774
4. Check minimum number of events None	3774
5. Include endpoints None	3774
6. Filter based on genotype QC (FinnGen only)	3774

Control definitions (FinnGen only)

Control exclude: O15_PREG_OTHER_MAT_DISORD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF3
Parent code in ICD-10: O20-O29
Name in latin: Abnormitates in examinatione antenatali matris repertae

NAME	O15_ANTENAT_ABNORM
CONTROL_EXCLUDE	O15_PREG_OTHER_MAT_DISORD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	O28
HD_ICD_9	7923
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	O28
COD_ICD_9	7923
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Abnormal findings on antenatal screening of mother based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	26387	26387	-
Only index persons	26230	26230	-
Unadjusted period prevalence (%)
Whole population	0.76	0.76	-
Only index persons	0.96	0.96	-
Median age at first event (years)
Whole population	-	29.93	-
Only index persons	-	29.93	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3774	3774	-
Unadjusted period prevalence (%)	1.29	1.29	-
Median age at first event (years)	30.69	30.69	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3007: Matched controls
30069

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

O28.1

ICD-10 Finland

Abnormal biochemical finding on antenatal screening of mother

+∞

323.0

642

O28.3

ICD-10 Finland

Abnormal ultrasonic finding on antenatal screening of mother

1442.6

323.0

836

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

5.9

323.0

1139

2800

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

4326.5

323.0

1344

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

117.5

323.0

778

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

5.6

316.0

1135

2947

SPAT1379

SPAT

Health check-up of pregnant person

4.2

266.7

1429

5382

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

3.7

239.8

1555

6720

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

271.3

223.4

226

SPAT1197

SPAT

Extensive health check-up of expecting family

3.5

220.4

1508

6656

O80.0

ICD-10 Finland

Spontaneous vertex delivery

3.5

216.5

2095

11983

W78

ICPC

Pregnancy

3.3

207.6

1617

7762

SPAT1380

SPAT

Postpartum check-up

3.6

195.6

1182

4609

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

4.0

191.6

943

3086

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

5.0

187.0

689

1694

W85

ICPC

Gestational diabetes

14.4

187.0

328

253

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

20.8

186.7

284

150

SPAT1196

SPAT

Monitoring of normal pregnancy

3.9

183.8

938

3149

O28.0

ICD-10 Finland

Abnormal haematological finding on antenatal screening of mother

859.7

167.4

163

W84

ICPC

Pregnancy high risk

6.5

161.2

457

810

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

2.8

156.8

1872

11100

Z39.2

ICD-10 Finland

Routine postpartum follow-up

2.9

154.4

1322

6340

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

2.8

139.0

1309

6542

O80.8

ICD-10 Finland

Other single spontaneous delivery

4.7

138.5

527

1303

SPAT1263

SPAT

Sampling

2.6

133.8

1662

9689

Z32.1

ICD-10 Finland

Pregnancy confirmed

3.0

133.6

961

4018

O20.0

ICD-10 Finland

Threatened abortion

30.8

133.4

180

O28.9

ICD-10 Finland

Abnormal finding on antenatal screening of mother, unspecified

655.4

128.4

126

O26.6

ICD-10 Finland

Liver disorders in pregnancy, childbirth and the puerperium

323.2

122.2

123

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

3.0

121.4

877

3634

WX234

NOMESCO Finland

Paracervical blockade

5.1

118.0

403

878

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

1140.1

113.3

110

O35.8

ICD-10 Finland

Maternal care for other (suspected) fetal abnormality and damage

6.6

110.8

303

501

W90

ICPC

Uncompl labour/delivery livebirth

3.6

108.4

565

1827

MAA00

NOMESCO Finland

Amniocentesis

8.0

107.4

256

346

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

5.7

105.8

326

627

XMA22

NOMESCO Finland

General examination of pregnant woman

3.3

101.7

584

2026

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

2.7

99.2

840

3767

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

2.3

96.2

1269

7187

SPAT1357

SPAT

Monitoring of problem during pregnancy

4.8

94.8

339

769

SPAT1301

SPAT

No procedures

2.3

87.4

1054

5644

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

13.0

85.1

154

124

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

7.2

85.1

216

319

SPAT1189

SPAT

Other ultrasound examination during pregnancy

3.7

84.4

408

1222

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

2.4

83.7

922

4697

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

5.7

83.2

253

475

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

3.2

80.9

483

1700

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

3.6

80.1

401

1233

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

3.1

79.3

504

1848

O23.5

ICD-10 Finland

Infections of the genital tract in pregnancy

+∞

77.4

MAX99

NOMESCO Finland

Assistance to normal delivery

2.3

76.5

910

4772

WX307

NOMESCO Finland

Obstetric epidural analgesia

2.4

75.9

778

3784

O02.1

ICD-10 Finland

Missed abortion

3.1

74.2

453

1612

SPAT1249

SPAT

Treatment-related counselling outside office

2.0

73.6

1457

9501

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.7

69.9

547

2279

SPAT1324

SPAT

Screening procedure

2.1

69.3

1111

6593

O99.80

ICD-10 Finland

The fear of childbirth

3.0

68.9

453

1689

O82.0

ICD-10 Finland

Delivery by elective caesarean section

3.3

67.2

374

1240

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.3

64.5

209

421

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.5

64.4

594

2701

W29

ICPC

Pregnancy symptom/complaint other

3.7

63.8

304

891

MBC10

NOMESCO Finland

Repair of obstetric laceration of vagina

4.4

63.6

247

602

SPAT1262

SPAT

Handing over of treatment supplies

3.5

61.8

309

941

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

3.7

60.8

291

854

ZXD05

NOMESCO Finland

Urgent procedure

2.0

60.6

1112

6869

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

2.4

57.2

548

2529

O36.8

ICD-10 Finland

Maternal care for other specified fetal problems

4.8

54.9

191

415

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

5.5

54.6

168

318

O21.9

ICD-10 Finland

Vomiting of pregnancy, unspecified

7.8

54.3

129

172

MAC96

NOMESCO Finland

Other induction or advancement of labour

3.7

53.7

250

715

O47.1

ICD-10 Finland

False labour at or after 37 completed weeks of gestation

3.1

53.3

322

1122

O42.9

ICD-10 Finland

Premature rupture of membranes, unspecified

3.1

52.3

314

1091

SPAT1310

SPAT

Counselling related to known health issue

1.9

52.1

998

6178

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.1

50.4

655

3465

FM1NE

NOMESCO Finland

Ultrasound examination of fetal heart

10.9

49.7

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.8

49.3

1437

10205

O35.9

ICD-10 Finland

Maternal care for (suspected) fetal abnormality and damage, unspecified

6.2

48.9

137

231

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.9

48.2

165

352

Z31.5

ICD-10 Finland

Genetic counselling

2.9

47.6

320

1196

O40

ICD-10 Finland

Polyhydramnios

6.8

46.8

121

183

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

3.3

46.5

249

794

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

2.6

46.1

371

1542

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.8

45.1

1014

6562

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

+∞

44.9

WX704

NOMESCO Finland

Intubation

3.1

43.3

257

882

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.9

43.2

733

4282

O03.9

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, without complication

2.7

43.2

313

1223

O32.1

ICD-10 Finland

Maternal care for breech presentation

2.6

42.7

339

1397

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

5.5

42.4

129

241

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.7

41.7

305

1197

MBA03

NOMESCO Finland

Curettage of uterus after delivery or abortion

3.6

41.4

197

572

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

40.9

1024

6807

WX720

NOMESCO Finland

Own respiration

4.5

40.8

151

350

B01AB05

ATC

enoxaparin; parenteral

2.0

40.5

583

3183

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

4.2

40.2

161

402

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

4.3

40.0

153

366

E66.9

ICD-10 Finland

Obesity, unspecified

4.2

40.0

158

390

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

2.4

38.4

373

1705

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

37.7

323

1384

SPAT1312

SPAT

General health counselling

1.7

37.5

1076

7405

WX725

NOMESCO Finland

Noninvasive ventilation

3.8

37.4

167

460

Z2221

NOMESCO Finland

Medical doctor

0.5

37.4

357

6402

Z35.4

ICD-10 Finland

Supervision of pregnancy with grand multiparity

8.6

36.6

O47.9

ICD-10 Finland

False labour, unspecified

3.8

36.3

161

441

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.1

36.0

211

717

O21.0

ICD-10 Finland

Mild hyperemesis gravidarum

14.5

36.0

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.5

35.9

174

513

R09

ICPC

Sinus symptom/complaint

2.2

35.1

391

1902

O61.0

ICD-10 Finland

Failed medical induction of labour

5.4

34.5

107

205

W27

ICPC

Fear of complications of pregnancy

4.6

34.5

123

275

A05AA02

ATC

ursodeoxycholic acid; oral

9.5

34.3

W92

ICPC

Compl labour/ delivery livebirth

3.2

34.2

191

627

O41.0

ICD-10 Finland

Oligohydramnios

3.5

33.9

166

493

O60

ICD-10 Finland

Preterm labour and delivery

3.2

33.6

189

621

A10BA02

ATC

metformin; oral

2.5

33.5

290

1247

WX230

NOMESCO Finland

Plexus blockade of nervus pudendus

4.1

33.5

134

335

O28.5

ICD-10 Finland

Abnormal chromosomal and genetic finding on antenatal screening of mother

+∞

33.4

O26.7

ICD-10 Finland

Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium

7.4

33.0

111

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.3

32.7

339

1595

P01AB01

ATC

metronidazole; oral, rectal

1.6

32.6

1209

8834

MAA10

NOMESCO Finland

Biopsy of chorionic villus

11.7

32.3

SPAT1153

SPAT

Removal of sutures

1.8

32.3

634

3842

SPAT1200

SPAT

Guidance for breast-feeding and breast care

2.6

32.1

247

994

TMW99

NOMESCO Finland

Other minor surgical procedure in obstetrics

5.6

31.9

174

O23.1

ICD-10 Finland

Infections of bladder in pregnancy

166.7

31.7

SPAT1193

SPAT

Pap smear

1.8

31.6

666

4124

WYA40

NOMESCO Finland

Assessment of oral health and treatment needs for family expecting first child

3.1

31.3

185

631

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

3.0

31.2

192

674

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.8

31.1

610

3688

Z29

ICPC

Social problem NOS

4.4

30.7

115

270

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

30.6

1181

8673

R51.80

ICD-10 Finland

Headache

1.8

30.4

567

3371

W05

ICPC

Pregnancy vomiting/nausea

5.5

29.9

171

J01DB01

ATC

cefalexin; oral

1.7

29.1

2425

21411

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

2.1

29.0

355

1795

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

3.4

28.9

148

456

O99.0

ICD-10 Finland

Anaemia complicating pregnancy, childbirth and the puerperium

4.8

28.6

206

O80.9

ICD-10 Finland

Single spontaneous delivery, unspecified

4.8

28.2

209

Z36.2

ICD-10 Finland

Other antenatal screening based on amniocentesis

19.8

27.4

MA4AT

NOMESCO Finland

Chorion biopsy with ultrasound guidance

6.3

27.1

118

Z87.5

ICD-10 Finland

Personal history of complications of pregnancy, childbirth and the puerperium

5.1

27.0

175

O14.9

ICD-10 Finland

Pre-eclampsia, unspecified

3.9

26.6

112

294

O02.0

ICD-10 Finland

Blighted ovum and nonhydatidiform mole

2.7

26.6

193

750

MAE00

NOMESCO Finland

Outlet vacuum delivery

2.0

26.6

364

1923

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

2.9

26.4

164

579

SPAT1187

SPAT

General ultrasound examination in early pregnancy

4.1

26.4

105

262

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

26.4

943

6727

SPAT1240

SPAT

Therapeutic discussion

1.8

26.3

524

3170

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

26.3

319

1606

SPAT1373

SPAT

Combined screening in early pregnancy

2.8

26.3

173

635

R4110

NOMESCO Finland

Physiotherapy

0.5

26.2

175

3562

WX320

NOMESCO Finland

Spinalanesthesy

1.8

26.2

490

2902

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

25.8

220

933

A02BC01

ATC

omeprazole; systemic

1.7

25.6

588

3714

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

25.5

371

2007

-1

NOMESCO Finland

1.5

25.4

1177

8909

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

25.3

1295

10023

SPAT1303

SPAT

Counselling and guidance related to growth and development

4.3

25.1

226

KMAK

NOMESCO Finland

1.5

25.0

1852

15522

O20.8

ICD-10 Finland

Other haemorrhage in early pregnancy

16.2

24.9

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

2.6

24.9

194

787

O72.2

ICD-10 Finland

Delayed and secondary postpartum haemorrhage

3.4

24.5

124

379

SPAT1391

SPAT

Counselling and guidance related to family situation

3.6

24.5

114

327

O72.0

ICD-10 Finland

Third-stage haemorrhage

2.8

24.4

158

574

Z82.7

ICD-10 Finland

Family history of congenital malformations, deformations and chromosomal abnormalities

7.3

23.7

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

23.6

825

5820

W30

ICPC

Pregnancy, Medical examin/health eval complete

4.5

23.6

189

O81.4

ICD-10 Finland

Vacuum extractor delivery

1.9

23.3

396

2264

N02BE01

ATC

paracetamol; systemic, rectal

1.6

23.0

2338

20793

SPAT1260

SPAT

Consultation of another employee

1.8

22.8

472

2875

O21.1

ICD-10 Finland

Hyperemesis gravidarum with metabolic disturbance

30.3

22.8

LGA20

NOMESCO Finland

Sterilisation by constriction of Fallopian tubes

5.1

22.6

144

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

5.0

22.3

146

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

22.2

425

2524

Z35

ICD-10 Finland

Supervision of high-risk pregnancy

4.9

22.2

151

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

22.1

1476

11959

SPAT1097

SPAT

Recording of ECG

2.3

21.6

215

988

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

4.6

21.5

170

XLD10

NOMESCO Finland

Gynaecological examination

6.5

21.4

A78

ICPC

Infectious disease other/NOS

3.1

21.4

118

386

G03GA01

ATC

chorionic gonadotrophin; parenteral

2.1

21.3

262

1322

MBA96

NOMESCO Finland

Other removal of retained products of conception after delivery or abortion

3.0

21.2

128

445

WX290

NOMESCO Finland

Other blockade of nerve

1.4

21.1

1603

13270

O36.4

ICD-10 Finland

Maternal care for intrauterine death

6.8

21.1

O03.1

ICD-10 Finland

Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage

3.2

20.1

109

353

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

20.0

2241

19930

O26.9

ICD-10 Finland

Pregnancy-related condition, unspecified

12.6

19.8

O48

ICD-10 Finland

Prolonged pregnancy

2.1

19.7

244

1235

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.9

19.4

284

1533

O14.0

ICD-10 Finland

Mild to moderate pre-eclampsia

3.0

19.3

114

392

MBA20

NOMESCO Finland

Expression of placenta

4.0

19.2

195

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

18.9

252

1312

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

2.2

18.9

194

904

O46.9

ICD-10 Finland

Antepartum haemorrhage, unspecified

2.9

18.3

115

410

O03.4

ICD-10 Finland

Spontaneous abortion, Incomplete, without complication

2.5

18.1

142

578

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.5

18.1

147

609

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

4.7

17.9

132

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

17.9

1758

15047

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

0.5

17.9

108

2290

EB1SA

SPAT

0.1

17.8

733

M54.5

ICD-10 Finland

Low back pain

1.5

17.7

911

6915

SPAT1192

SPAT

Gynaecological examination

1.5

17.6

664

4714

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.6

17.6

596

4130

O64.0

ICD-10 Finland

Obstructed labour due to incomplete rotation of fetal head

2.4

17.5

147

621

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

17.3

1907

16605

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.7

17.2

349

2102

Z30.2

ICD-10 Finland

Sterilization

1.8

17.1

335

1996

R75

ICPC

Sinusitis acute/chronic

2.1

17.0

198

977

EB1AA

SPAT

0.2

17.0

734

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

5.4

16.9

Z12

ICPC

Relationship problem with partner

2.7

16.7

116

441

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

16.7

2137

19057

W31

ICPC

Pregnancy, Medical examin/health eval partial

2.6

16.4

122

484

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

16.2

147

645

O63.0

ICD-10 Finland

Prolonged first stage (of labour)

2.3

16.2

148

655

O22.0

ICD-10 Finland

Varicose veins of lower extremity in pregnancy

19.3

15.5

W03

ICPC

Antepartum bleeding

3.7

15.5

183

MAC01

NOMESCO Finland

Rupture of aminiotic membrane for induction of labor

2.5

15.4

118

474

Z35.1

ICD-10 Finland

Supervision of pregnancy with history of abortive outcome

4.9

15.4

104

H01

ICPC

Ear pain/earache

1.7

15.3

366

2310

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

15.3

507

3484

AA1AD

NOMESCO Finland

CT of head and brain

1.7

15.2

309

1862

O41.1

ICD-10 Finland

Infection of amniotic sac and membranes

3.6

14.9

189

K02.1

ICD-10 Finland

Caries of dentine

1.4

14.9

1811

15819

MBA40

NOMESCO Finland

Pharmacological evacuation of uterus after abortion

2.5

14.8

115

469

WX110

SPAT

0.2

14.7

788

J01CA08

ATC

pivmecillinam; oral

1.4

14.7

1461

12343

O28.4

ICD-10 Finland

Abnormal radiological finding on antenatal screening of mother

+∞

14.6

SPAT1388

SPAT

Extensive health check-up based on individual need

6.3

14.5

O21

ICD-10 Finland

Excessive vomiting in pregnancy

4.1

14.5

139

O70.0

ICD-10 Finland

First degree perineal laceration during delivery

3.3

14.3

217

SPAT1044

SPAT

Tympanometry

2.8

14.3

325

O85

ICD-10 Finland

Puerperal sepsis

3.4

14.2

202

MBA00

NOMESCO Finland

Vacuum aspiration from uterus after delivery or abortion

2.6

14.2

107

426

XMA20

NOMESCO Finland

Early examination of pregnancy

2.7

14.1

354

MAC98

NOMESCO Finland

Other induction of labor

12.0

14.1

O32.2

ICD-10 Finland

Maternal care for transverse and oblique lie

4.2

14.1

124

MAC02

NOMESCO Finland

Rupture of aminiotic membrane for advancement of labor

4.4

13.9

116

Z39.1

ICD-10 Finland

Care and examination of lactating mother

2.2

13.9

137

627

SPAT1393

SPAT

Guidance to support interaction between parent and child

4.1

13.8

131

OAA41

SPAT

3.3

13.8

213

Z3231

NOMESCO Finland

Registered nurse

0.6

13.7

272

4155

R21

ICPC

Throat symptom/complaint

1.4

13.7

862

6724

O35.0

ICD-10 Finland

Maternal care for (suspected) central nervous system malformation in fetus

8.6

13.7

O28.2

ICD-10 Finland

Abnormal cytological finding on antenatal screening of mother

+∞

13.5

O23.0

ICD-10 Finland

Infections of kidney in pregnancy

+∞

13.5

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

+∞

13.5

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

13.5

1576

13574

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

13.5

823

6383

LCH11

NOMESCO Finland

Pharmacologic abortion

1.7

13.5

291

1782

MBC30

NOMESCO Finland

Repair of partial rupture of perineum

2.3

13.3

128

579

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

13.2

475

3317

Z27

ICPC

Fear of a social problem

5.1

13.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

13.2

413

2792

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

13.2

267

1607

SPAT1254

SPAT

Administration of medicine

1.7

13.1

286

1758

Z3226

NOMESCO Finland

Physiotherapist

0.5

13.0

140

2486

C08CA05

ATC

nifedipine; systemic

2.5

12.9

398

SPAT1383

SPAT

Extensive health check-up at 4 years of age

3.0

12.9

250

O22.2

ICD-10 Finland

Superficial thrombophlebitis in pregnancy

50.2

12.8

D68.8

ICD-10 Finland

Other specified coagulation defects

4.0

12.8

126

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

12.8

157

791

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.0

12.8

170

886

-31

ICPC

Medical examin/health eval partial

1.9

12.8

176

929

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

12.8

225

1294

J03.0

ICD-10 Finland

Streptococcal tonsillitis

2.1

12.7

149

739

P02

ICPC

Acute stress reaction

1.8

12.7

223

1281

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.9

12.5

192

1054

O26.0

ICD-10 Finland

Excessive weight gain in pregnancy

+∞

12.5

Z37.0

ICD-10 Finland

Single live birth

0.7

12.5

315

4581

L03

ICPC

Low back symptom/complaint

1.4

12.5

628

4689

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

3.2

12.5

202

ZXD10

NOMESCO Finland

Scheduled procedure

0.7

12.3

473

6370

O12.0

ICD-10 Finland

Gestational oedema

4.5

12.2

N61

ICD-10 Finland

Inflammatory disorders of breast

2.1

12.2

142

703

A31

ICPC

General and Unspecified, Medical examin/health eval partial

2.7

12.0

316

O73.1

ICD-10 Finland

Retained portions of placenta and membranes, without haemorrhage

3.6

12.0

149

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

12.0

1520

13149

W99

ICPC

Disorder of pregn/delivery other

4.4

12.0

SPAT1283

SPAT

Restricted health certificate

1.4

11.9

883

7045

O03.6

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, complicated by delayed or excessive haemorrhage

3.7

11.9

135

K04.0

ICD-10 Finland

Pulpitis

1.6

11.8

343

2274

O30.0

ICD-10 Finland

Twin pregnancy

2.6

11.8

346

WX290

SPAT

0.2

11.8

520

XF400

NOMESCO Finland

ECG with 12 standard connections

0.4

11.8

1190

W18

ICPC

Post-partum symptom/complaint other

3.6

11.7

147

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

0.4

11.7

987

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

11.6

522

3811

SPAT1315

SPAT

Periodic health check-up of children and adolescents

1.7

11.5

230

1376

O44.1

ICD-10 Finland

Placenta praevia with haemorrhage

4.2

11.5

100

MBA30

NOMESCO Finland

Manual removal of placenta from delivered uterus

2.3

11.5

102

445

SPAT1392

SPAT

Counselling and guidance related to couple relationship

3.4

11.3

162

O30.00

ICD-10 Finland

Twin pregnancy with separate amniotic and chorionic sacs

4.7

11.3

O23.4

ICD-10 Finland

Unspecified infection of urinary tract in pregnancy

35.1

11.3

G03DB01

ATC

dydrogesterone; oral

1.4

11.2

503

3667

O33.5

ICD-10 Finland

Maternal care for disproportion due to unusually large fetus

6.2

11.2

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

11.2

390

2698

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

11.1

304

1982

MA3AE

SPAT

4.3

11.1

R74

ICPC

Upper respiratory infection acute

1.3

11.1

1148

9607

VALMI

NOMESCO Finland

1.4

11.0

815

6489

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

7.4

10.9

X01

ICPC

Genital pain female

3.1

10.9

195

S18

ICPC

Laceration/cut

1.4

10.8

717

5603

ZXH06

SPAT

2.8

10.8

254

ZXH09

SPAT

2.4

10.7

378

Z39.0

ICD-10 Finland

Care and examination immediately after delivery

2.5

10.7

316

O00.9

ICD-10 Finland

Ectopic pregnancy, unspecified

2.9

10.6

227

ZXD00

NOMESCO Finland

Emergency procedure

2.2

10.6

100

454

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.4

10.5

356

O12.1

ICD-10 Finland

Gestational proteinuria

3.9

10.5

105

O72.1

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1167

2705

5.80

307.65

2.0

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1336

3154

6.01

307.65

1.7

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1132

2365

6.41

307.65

1.6

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1218

4845

3.24

226.93

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1516

7154

2.87

204.23

1.7

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

461

1076

4.74

184.22

2.7

1.5

umol/l

3.9

3.7

0.47

372

768

(3019832) Treponema pallidum Ab [Presence] in Serum

1933

11139

2.51

164.01

1.9

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2044

12300

2.44

154.60

2.0

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2125

13615

2.28

130.85

3.9

3.5

mmol/l

5.9

0.20

1642

11861

(3019150) Specific gravity of Urine by Refractometry

1249

6493

2.38

125.25

4.0

2.9

kg/l

1.0

1.51

252

990

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1040

5107

2.43

117.40

2.9

2.1

u/l

13306.8

4908.2

7.33

547

1946

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

327

914

3.82

101.08

1.9

1.5

mmol/l

7.4

7.0

1.84

147

575

(3031040) Bacteria [#/volume] in Urine by Automated count

2804

21280

2.24

99.44

5.0

3.4

e6/l

1399.4

1523.3

0.04

194

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

926

4646

2.32

97.02

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2833

21918

2.17

90.62

4.8

3.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1819

12031

1.99

90.51

4.0

2.8

—

(3026008) Bacteria identified in Urine by Culture

1340

8032

2.04

87.46

2.6

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2141

15123

1.96

86.37

5.1

3.7

—

(3047181) Lactate [Moles/volume] in Blood

213

523

4.26

78.41

3.3

5.0

mmol/l

1.1

1.2

0.94

192

465

(3032080) INR in Blood by Coagulation assay

1072

6239

2.00

73.57

3.0

3.7

inr

1.0

1.39

343

2281

(46235355) HIV 1 and 2 tests - Meaningful Use set

2109

15428

1.83

69.96

2.2

2.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1269

7935

1.90

69.73

4.3

3.0

estimate

0.0

2.55

415

3041

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1151

7263

1.84

59.55

2.4

2.3

u/l

53.2

54.9

0.55

1080

6742

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

190

526

3.75

59.11

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

225

709

3.31

57.38

4.7

6.7

mmol/l

23.1

23.9

2.48

209

657

(3035350) Ketones [Presence] in Urine by Test strip

2058

15486

1.72

56.82

3.9

2.8

estimate

0.0

0.88

409

2960

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

207

648

3.32

53.32

1.9

1.4

mmol/l

6.4

0.03

130

473

(3009261) Glucose [Presence] in Urine by Test strip

2059

15655

1.69

53.26

4.0

2.9

estimate

0.0

0.10

416

3040

(3021601) Nitrite [Presence] in Urine by Test strip

2047

15540

1.69

53.25

5.0

4.0

estimate

0.0

1.34

422

3096

(3019060) Gas panel - Arterial blood

202

675

3.11

46.65

3.9

5.1

—

(3039000) Anion gap in Blood

119

290

4.20

44.15

4.4

7.3

mmol/l

11.5

11.1

0.65

111

258

(3018572) Chloride [Moles/volume] in Blood

119

291

4.19

43.95

4.4

7.3

mmol/l

106.2

106.0

0.16

111

259

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

376

1799

2.21

41.52

1.4

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

366

1749

2.21

40.51

1.3

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

157

495

3.27

39.93

3.9

5.2

1.9

1.8

0.77

148

460

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

226

883

2.66

39.06

2.0

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

156

497

3.23

39.00

3.9

5.3

1.0

0.9

2.06

148

463

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1530

11508

1.55

36.02

3.8

4.6

umol/l

8.9

9.3

0.69

1435

10733

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1023

7051

1.62

34.82

2.0

mg/l

2.4

2.5

2.31

927

6049

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

10.36

34.23

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

529

3060

1.85

33.96

1.7

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

490

2803

1.86

32.51

1.5

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

228

991

2.38

31.41

1.6

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

110

323

3.48

31.34

1.2

1.1

iu/ml

4.1

29980.9

0.60

(40761511) CBC panel - Blood by Automated count

3618

33971

2.58

30.91

11.4

7.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

114

347

3.36

30.71

1.4

1.3

—

(40761535) Cells panel - Urine sediment

310

1544

2.10

30.64

3.2

3.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

186

756

2.54

29.62

1.8

2.4

ng/l

36.8

64.4

2.51

168

667

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

313

3.42

29.24

1.4

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1201

8866

1.52

29.21

3.6

4.0

g/l

35.8

37.5

18.57

1121

8228

(3041096) Erythrocytes [Presence] in Urine by Automated

1250

9324

1.51

28.85

3.2

2.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

123

411

3.06

28.41

2.1

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

483

2876

1.78

27.85

1.4

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

234

1085

2.23

27.69

4.2

7.6

g/l

124.7

121.3

1.76

221

1041

(3037121) Protein [Mass/volume] in Urine

155

599

2.66

27.36

2.7

2.8

g/l

0.3

0.19

247

(3016502) Oxygen saturation in Arterial blood

238

1123

2.19

26.98

4.3

7.4

97.7

96.6

2.86

221

1070

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

931

6606

1.54

26.77

1.9

1.7

mg/l

1.0

0.8

2.09

700

4726

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

937

6676

1.54

26.38

2.0

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3117

28183

1.61

26.22

7.2

mmol/l

139.3

139.4

1.16

3044

27267

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2331

19861

1.45

26.07

3.5

2.9

ug/l

45.8

54.0

5.75

2246

19008

(3023103) Potassium [Moles/volume] in Serum or Plasma

3121

28246

1.61

25.94

7.2

mmol/l

3.9

1.12

3045

27236

(3026493) Urate [Moles/volume] in Serum or Plasma

725

4925

1.58

25.06

2.3

1.8

umol/l

1391.9

2100.5

0.49

671

4479

(3003694) ABO and Rh group [Type] in Blood

1597

12790

1.43

24.40

2.2

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

491

3069

1.69

23.59

2.3

ng/l

156.9

252.9

0.52

174

1109

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

154

648

2.44

22.80

4.8

8.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1503

12039

1.41

22.31

1.7

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

303

1699

1.85

21.11

2.7

3.7

u/l

207.5

223.1

1.82

285

1608

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2225

19171

1.39

20.87

5.3

5.9

u/l

68.7

67.5

1.01

2137

18061

(3006184) Hemoglobin [Mass/volume] in Capillary blood

105

385

2.78

20.58

3.0

1.8

g/l

129.1

132.0

0.77

297

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2946

26727

1.47

20.17

4.9

4.1

pmol/l

14.1

0.05

2819

25194

(3029396) Erythrocyte agglutination [Presence] in Blood

323

2.93

20.15

4.3

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1917

0.33

19.38

1.4

—

(3003396) Base excess in Arterial blood by calculation

249

1363

1.89

18.69

4.2

6.7

mmol/l

1.3

0.4

4.46

142

975

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2437

27004

0.72

18.59

5.6

6.6

ml/min/173m2

100.0

98.9

2.40

1894

21281

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3371

31601

1.63

18.51

9.3

8.5

mg/l

17.4

18.2

0.87

2740

23344

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

854

6352

1.45

18.42

2.0

2.1

ng/l

12.4

21.7

1.19

222

1743

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

325

1939

1.74

18.34

2.8

2.1

—

(4034850)

163

780

2.14

17.85

5.5

6.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

214

3819

0.53

17.75

1.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

242

1355

1.84

16.91

4.3

6.7

kpa

4.6

4.9

6.07

229

1290

(3027801) Oxygen [Partial pressure] in Arterial blood

242

1355

1.84

16.91

4.2

6.7

kpa

13.6

14.8

2.91

229

1290

(40761536) Microorganisms panel - Urine sediment

429

2808

1.60

16.90

3.8

2.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

178

903

2.02

16.70

1.6

2.4

g/l

3.9

3.5

3.20

161

842

(3018677) aPTT in Platelet poor plasma by Coagulation assay

412

2681

1.60

16.62

1.6

2.0

27.3

29.0

16.84

389

2571

(3012516) Albumin [Mass/volume] in Urine

449

2986

1.57

16.51

2.8

3.3

mg/l

974.4

504.1

0.67

311

1905

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1193

9556

1.36

16.32

2.9

2.8

u/l

27.2

26.7

0.13

1137

9171

(3020682) Albumin/Creatinine [Ratio] in Urine

460

3099

1.55

15.95

3.5

3.9

mg/mmol

11.7

15.6

1.09

327

2046

(3047352) Trisomy 18 risk [Likelihood] in Fetus

195

3459

0.54

15.75

1.6

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1076

8535

1.36

15.50

2.1

1.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

203

3540

0.55

15.45

1.8

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

195

3433

0.54

15.33

2.2

e6/l

4.1

5.3

1.44

116

1677

(3020891) Body temperature

104

444

2.38

15.01

3.0

4.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

240

2.91

15.00

1.2

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

110

2293

0.46

14.53

2.1

u/l

36.7

35.4

0.12

1950

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.42

14.46

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3202

29991

1.45

14.38

5.4

4.7

mu/l

1.5

2.0

3.17

3093

28794

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

298

2.65

14.23

1.1

1.2

ratio

1.1

1.0

0.25

118

(3005033) Fetal Nuchal fold Thickness US

202

3446

0.56

14.16

1.7

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

235

1377

1.75

14.11

1.1

u/ml

6.6

2.7

0.61

245

(3021589) Normoblasts [#/volume] in Blood

1073

13110

0.75

14.11

7.8

7.2

e9/l

0.0

0.02

978

10749

(3007461) Platelets [#/volume] in Blood

3720

36252

2.86

14.08

14.7

12.9

e9/l

264.7

270.8

8.96

3697

35574

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1421

11883

1.31

13.94

2.0

1.7

—

(3010813) Leukocytes [#/volume] in Blood

3723

36308

2.92

13.84

14.8

12.9

e9/l

7.2

6.8

23.61

3697

35578

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

309

1963

1.63

13.71

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

4.95

13.56

1.7

1.2

—

(3024731) MCV [Entitic volume]

3721

36293

2.83

13.55

14.7

12.8

89.0

89.7

19.75

3703

35986

(3035941) MCH [Entitic mass]

3721

36294

2.83

13.53

14.7

12.8

29.8

29.9

3.52

3704

35984

(3026361) Erythrocytes [#/volume] in Blood

3721

36297

2.83

13.47

14.7

12.9

e12/l

4.4

4.5

4.91

3697

35602

(3000963) Hemoglobin [Mass/volume] in Blood

3722

36316

2.84

13.39

14.8

12.9

g/l

131.6

132.7

9.74

3705

36003

(3033658) Prothrombin time (PT) actual/Normal

415

5821

0.68

12.33

2.3

3.0

98.4

0.02

391

5609

(44806118)

226

2.73

11.87

1.2

1.4

—

(44790049)

226

2.73

11.87

1.2

1.4

—

(44790047)

226

2.73

11.87

1.2

1.4

—

(44790048)

226

2.73

11.87

1.2

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

873

6945

1.33

11.79

4.3

2.8

—

(40758558) Short blood count panel - Blood

518

6922

0.71

11.68

4.1

6.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

132

687

1.95

11.60

1.3

u/ml

16.1

18.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1171

9739

1.29

11.38

4.1

4.8

mmol/l

1.2

0.34

946

8242

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

130

679

1.95

11.32

2.8

2.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2359

21388

1.27

11.26

3.5

3.4

mm/h

8.0

8.2

0.48

2266

20165

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1310

0.39

11.09

1.3

—

(3003338) MCHC [Mass/volume]

3171

29936

1.37

11.08

12.1

10.6

g/l

334.1

332.4

25.74

3156

29679

(3040151) Glucose [Moles/volume] in Capillary blood

195

2.79

11.05

5.7

2.6

mmol/l

5.5

6.8

0.96

158

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

601

4556

1.38

11.03

1.5

pmol/l

62289336.2

35249741.9

0.44

533

4071

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

297

2.42

10.82

1.2

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

718

5616

1.34

10.76

1.3

u/ml

6.8

8.3

0.33

293

2462

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

125

657

1.93

10.70

1.3

u/ml

110.0

104.9

0.42

147

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

754

5956

1.33

10.55

1.3

iu/ml

16.1

23.2

0.96

274

1798

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

206

2.69

10.52

1.0

1.1

91.7

86.9

0.81

173

(3043409) Potassium [Moles/volume] in Arterial blood

320

2.34

10.49

3.1

3.9

mmol/l

3.8

3.7

0.13

300

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

129

693

1.89

10.36

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

398

2.16

9.99

1.2

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

406

2.14

9.90

1.2

1.5

—

(36660697) Celiac disease serology panel - Serum

451

3330

1.40

9.63

1.2

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

3026

28561

1.30

9.15

10.7

10.4

13.3

2.43

2983

28020

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3355

32153

1.39

9.09

7.3

7.0

u/l

24.2

22.4

3.52

3277

31213

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

315

4395

0.69

8.88

1.6

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

172

1054

1.66

8.85

2.1

2.2

iu/l

3.5

4.1

0.59

470

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

184

2.63

8.83

1.1

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

170

2.67

8.53

1.1

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

378

2.09

8.45

2.2

2.0

ug/l

3.0

1.7

0.20

330

(3023368) Bacteria identified in Blood by Culture

559

4358

1.33

8.42

2.6

3.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

356

4819

0.71

8.41

1.7

1.6

1.3

0.57

320

4405

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

338

0.15

8.36

23.2

18.6

nmol/l

981.6

4335.5

—

324

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

108

589

1.86

8.35

1.9

2.0

g/l

1.2

0.14

516

(3009508) Creatinine [Moles/volume] in Urine

626

4968

1.31

8.30

2.9

3.0

mmol/l

8.0

0.11

572

4340

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2436

22518

1.23

8.24

3.5

3.0

mmol/mol

35.9

35.4

2.18

2324

21530

(4035726)

1667

0.54

7.96

1.2

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

327

0.15

7.88

17.2

13.3

nmol/l

611.2

871.5

—

315

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

107

597

1.82

7.72

1.4

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

223

1503

1.51

7.69

1.2

1.3

u/ml

0.3

1.5

2.24

120

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

364

2693

1.39

7.66

3.7

3.5

pmol/l

4.7

4.6

1.12

341

2433

(40768804) Tissue Pathology biopsy report

1098

12662

0.81

7.49

1.8

1.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

159

2.60

7.43

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

100

1734

0.57

7.43

1.6

1.5

—

(3022621) pH of Urine by Test strip

259

1816

1.46

7.36

3.3

2.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

319

2.09

7.25

1.2

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

3.77

7.07

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

649

5288

1.27

6.95

1.7

1.9

u/l

129.3

127.1

0.03

618

5026

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

307

4125

0.72

6.88

1.6

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

254

2.18

6.81

1.1

1.2

u/ml

2.3

22.0

—

(3018095) Leukocytes [#/volume] in Urine

802

9482

0.80

6.79

2.9

e6/l

53.2

63.7

0.40

619

5593

(3043410) Blood group antigens tested for on Red Blood Cells

3.40

6.69

1.3

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

313

4155

0.73

6.48

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

313

4151

0.73

6.44

1.6

1.4

—

(3008898) HLA-B27 [Presence]

279

2034

1.40

6.42

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

719

0.38

6.38

1.5

3.4

mmol/l

24.1

24.2

0.02

643

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

460

0.24

6.35

1.3

1.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1095

9526

1.21

6.35

1.3

u/ml

1.4

1.5

0.01

313

2771

(3044889) 12 lead EKG panel

1730

15695

1.19

6.31

2.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

206

2.25

6.16

1.2

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3265

31471

1.28

6.09

4.3

4.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

355

2720

1.34

5.99

1.3

u/ml

168.1

219.0

0.53

320

2537

(3017143) Hepatitis C virus Ab [Presence] in Serum

789

6676

1.23

5.98

1.7

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

292

2177

1.37

5.89

3.9

3.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

319

4137

0.75

5.63

1.6

1.4

—

(3029612) Listeria sp Ab [Titer] in Serum

5.90

5.62

1.5

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

235

2.10

5.58

1.1

miu/ml

1259.5

1437.0

0.55

235

(3001019) Free T4 and TSH panel - Serum or Plasma

272

3593

0.74

5.44

1.3

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

292

1.97

5.44

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

166

2.30

5.43

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2807

26731

1.20

5.31

2.8

mmol/l

5.4

3.62

2673

25356

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

538

1.69

5.24

1.2

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

113

716

1.60

5.23

1.4

1.2

mmol/l

3.4

3.5

0.04

107

667

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

222

2.09

5.18

1.7

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

371

1.82

5.08

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

380

3018

1.29

4.96

1.7

1.6

nmol/l

1173.4

1170.9

0.02

338

2384

(3000850) Epithelial cells [#/volume] in Urine

556

4623

1.24

4.92

2.2

2.1

e6/l

9.6

10.3

0.39

516

3938

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

304

1.89

4.88

1.2

—

(3042936) Bacteria identified in Isolate by Culture

383

3052

1.28

4.87

2.0

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

534

0.39

4.78

1.4

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

364

4538

0.78

4.75

1.4

—

(40768793) Breast Pathology biopsy report

894

0.53

4.68

1.1

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

204

2.07

4.68

2.3

2.8

ug/min

82.6

134.1

0.46

129

(3015183) Erythrocyte sedimentation rate

283

1.89

4.54

1.0

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

568

4774

1.22

4.52

1.4

titre

608.2

602.5

0.02

107

927

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

110

725

1.53

4.36

1.4

e6/l

711.0

6805.8

0.63

103

591

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

110

725

1.53

4.36

1.4

e6/l

9.7

18.6

1.33

561

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.10

4.35

3.5

5.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

476

3950

1.23

4.28

1.3

1.2

iu/ml

101.7

151.4

3.39

229

1555

(3052851) Hemolysis interference index of Serum or Plasma

632

0.47

4.28

2.1

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

282

3567

0.77

4.14

2.0

2.1

e6/l

1.0

0.07

199

1809

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

587

6851

0.83

4.10

1.9

1.7

—

(3020491) Glucose [Moles/volume] in Blood

222

1.95

4.10

1.8

1.4

mmol/l

5.8

5.5

0.24

188

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

301

1.81

4.08

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

322

2570

1.28

4.07

1.4

—

(3025130) Human papilloma virus identified in Specimen

1295

0.64

4.00

1.5

1.8

—

(3012501) Base excess in Blood by calculation

350

1.73

3.91

1.8

2.2

mmol/l

1.5

1.7

0.59

189

(3022948) Iron [Moles/volume] in Serum or Plasma

431

3578

1.23

3.87

1.9

2.1

umol/l

15.0

15.1

0.07

400

3325

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

300

1.78

3.83

1.1

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

3.07

3.80

1.3

1.1

—

(3017732) Neutrophils [#/volume] in Blood

290

2309

1.28

3.75

1.6

2.0

e9/l

4.5

4.2

0.49

257

1986

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

170

2272

0.74

3.73

1.2

1.3

ug/l

3.0

3.2

0.41

156

2152

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

154

1121

1.39

3.70

1.9

2.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

264

3303

0.78

3.57

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

391

0.41

3.42

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

391

0.41

3.42

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

262

2089

1.27

3.38

2.0

2.4

g/l

10.8

10.5

0.48

244

1919

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

168

1.97

3.33

1.2

1.1

98.0

96.1

0.20

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

113

796

1.43

3.31

1.1

—

(4010399)

195

1504

1.31

3.25

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

3287

32078

1.19

3.23

10.0

9.4

38.7

39.6

7.02

2422

27673

(3006653) Thiamine [Moles/volume] in Blood

129

2.10

3.23

1.6

nmol/l

131.7

131.4

0.01

129

(21494755) Public health laboratory ask at order entry panel

491

5704

0.84

3.23

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

112

797

1.42

3.12

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

166

1.94

3.09

1.1

104.5

96.9

0.62

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.08

3.09

1.1

1.0

—

(3002256) Pathology report gross observation

297

3601

0.81

3.06

1.2

—

(3010421) pH of Blood

410

1.57

2.98

1.8

2.3

7.4

0.15

348

(3021879) Hepatitis B virus core Ab [Presence] in Serum

369

4363

0.83

2.95

1.5

—

(3025941) Bacteria identified in Stool by Culture

272

2218

1.24

2.93

1.3

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

3.34

2.90

1.3

1.4

24.4

29.8

—

(4306422)

617

1.45

2.88

1.1

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.67

2.86

1.0

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

297

1.66

2.86

1.0

1.2

nmol/l

—

0.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.34

2.81

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.34

2.81

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

354

1.59

2.78

3.2

2.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

205

0.34

2.78

2.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

297

0.40

2.71

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

296

0.40

2.69

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

296

0.40

2.69

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

131

985

1.34

2.66

3.2

2.4

—

(3004451) EKG impression Narrative

3.13

2.64

1.3

1.1

—

(4027681)

359

1.57

2.64

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

163

0.31

2.54

1.0

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

213

1720

1.25

2.54

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

1346

0.73

2.52

2.9

2.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

301

0.43

2.52

1.1

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

372

3181

1.19

2.51

1.9

2.1

g/l

2.6

2.5

2.81

348

2957

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

300

0.43

2.50

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

300

0.43

2.50

1.1

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

943

8630

1.12

2.47

3.6

4.2

mmol/l

1.2

4.54

849

7879

(3000492) Spirometry study

257

3086

0.82

2.44

1.2

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.24

2.44

1.0

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

345

2940

1.19

2.43

1.9

nmol/l

381.6

388.6

0.27

314

2717

(40758292) HTLV I+II Ab panel - Serum

0.00

2.42

0.0

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

283

3363

0.83

2.42

1.9

2.1

mmol/l

2.4

0.01

253

2894

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1130

12175

0.90

2.42

2.2

nmol/l

70.9

72.3

1.23

1078

11559

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.00

2.41

0.0

1.9

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

361

0.50

2.38

1.4

1.5

mu/l

242.8

514.4

6.33

342

(40757373) Influenza virus identified in Isolate

3.64

2.36

1.1

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

711

1.37

2.36

1.4

2.2

ug/l

10.1

4.5

0.34

606

(3020191) Ethanol [Moles/volume] in Serum or Plasma

236

1.66

2.35

1.3

1.6

promille

1.0

1.2

0.47

190

(4281824)

305

0.46

2.34

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

169

1.78

2.32

1.8

1.5

nmol/l

1.6

1.3

0.20

125

(3000991) Gas panel - Venous blood

1131

0.72

2.31

3.7

7.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

199

1.71

2.31

1.3

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

370

0.51

2.31

1.4

1.5

77.6

72.7

2.47

351

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

380

1.51

2.30

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

843

0.68

2.22

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

786

7161

1.12

2.21

1.6

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

180

1453

1.25

2.19

2.1

2.7

mmol/l

1.2

0.95

145

1260

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.50

2.18

1.7

3.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.50

2.18

1.7

3.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

222

2670

0.82

2.17

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

502

1.42

2.15

3.4

2.9

mg/l

18.2

24.0

1.29

293

(40768441) Liver Pathology biopsy report

181

0.39

2.15

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

227

1.64

2.14

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

137

1.83

2.13

1.5

1.4

pmol/l

12.3

13.1

0.61

118

(40768797) Stomach Pathology biopsy report

265

3126

0.84

2.12

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

691

1.35

2.11

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

136

1069

1.28

2.08

1.4

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

913

0.71

2.08

1.6

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.91

2.07

1.9

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

2.06

0.0

6.8

—

(3018010) Neutrophils/100 leukocytes in Blood

1402

14845

0.91

2.04

4.0

5.3

57.2

56.3

2.57

1340

14092

(3003157) Bacteria [#/volume] in Mother's milk

3.08

2.01

5.9

7.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

148

0.34

1.99

1.6

2.2

nmol/l

148.0

170.1

—

128

(1616796) Gas panel - Central venous blood

353

1.48

1.97

1.6

2.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

428

1.43

1.95

1.1

mg/l

192.2

195.2

0.06

369

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

162

1312

1.25

1.95

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

2.03

1.95

2.8

2.3

nmol/l

1.2

1.5

0.39

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

203

0.44

1.95

1.4

1.3

—

98.0

—

(3024928) Oxygen saturation in Venous blood

283

0.49

1.95

1.4

2.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

423

0.59

1.93

4.1

3.7

u/ml

17.6

24.3

0.75

404

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

298

2565

1.18

1.92

1.8

2.3

umol/l

5.3

5.1

0.09

234

2094

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

596

5390

1.13

1.90

1.6

1.5

mmol/l

1.3

0.67

538

4905

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

196

1.64

1.89

1.1

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

111

862

1.30

1.89

2.3

2.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

1425

15035

0.92

1.87

4.0

5.5

29.9

30.3

1.05

1358

14234

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

441

1.41

1.86

1.2

mg/l

40.7

35.0

0.30

362

(3017704) Immunofixation for Urine

2.86

1.86

1.1

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

395

3485

1.15

1.85

1.4

1.6

mu/l

255.8

320.5

3.28

351

3105

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

553

1.36

1.83

1.7

3.0

0.7

0.29

532

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

226

1909

1.20

1.82

2.4

2.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

684

1.32

1.80

1.2

1.3

titre

54.0

111.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

1.89

1.80

1.3

1.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

187

1553

1.21

1.80

1.6

1.8

g/l

1.3

0.03

176

1440

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

168

1.67

1.80

1.4

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

473

0.63

1.76

1.4

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

256

1.53

1.75

1.2

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

319

2783

1.16

1.75

1.9

2.2

24.7

24.5

0.09

219

2423

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

416

1.40

1.69

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

111

1.81

1.68

1.7

2.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

134

1.72

1.66

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

260

1.51

1.65

1.3

1.6

pmol/l

388.8

451.2

0.31

205

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

213

0.47

1.65

3.7

3.5

u/ml

30.6

37.0

—

213

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.80

1.65

1.1

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

225

0.49

1.62

1.9

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

114

1417

0.80

1.60

1.6

1.7

—

(4024509)

191

1.58

1.56

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

201

2355

0.85

1.55

2.5

2.3

au/ml

14.5

21.0

0.54

216

(3012494) Peanut IgE Ab [Units/volume] in Serum

168

1.61

1.55

1.1

u/ml

0.3

3.1

1.63

105

(3023323) Follitropin [Units/volume] in Serum or Plasma

374

4185

0.88

1.54

1.3

iu/l

17.8

21.0

1.52

339

3602

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

3.34

1.52

1.0

1.1

—

(3013512) EKG study

504

4577

1.12

1.52

2.3

2.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

816

0.74

1.52

1.5

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

209

1.54

1.51

1.1

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.86

1.50

1.2

—

(3022689) Creatine [Moles/volume] in Urine

0.00

1.49

0.0

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

874

8165

1.09

1.49

3.3

3.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

196

1669

1.18

1.49

3.4

6.0

mmol/l

106.0

105.2

2.42

189

1645

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.07

1.49

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1005

0.77

1.49

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

188

2202

0.85

1.46

1.4

1.2

au/ml

25.2

29.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

195

1.54

1.45

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.92

1.43

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

227

0.53

1.43

1.0

2.6

57.4

63.9

0.52

227

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1194

12569

0.93

1.40

2.2

2.3

—

(3028717) Thiamine [Mass/volume] in Blood

2.25

1.40

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.18

1.39

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

181

1.55

1.39

1.2

1.1

nmol/l

0.1

2.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

139

0.43

1.39

1.2

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.61

1.36

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.94

1.36

1.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

747

8004

0.92

1.35

1.3

1.4

g/l

2.0

0.33

537

5271

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

135

1.63

1.35

1.1

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

135

1.63

1.35

1.1

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

135

1.63

1.35

1.1

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

627

0.73

1.33

1.3

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

405

0.66

1.32

1.1

82.0

92.2

1.33

374

(3022096) Basophils/100 leukocytes in Blood

1297

13585

0.93

1.31

3.9

5.7

0.6

0.7

1.57

1232

12754

(3014599) Egg white IgE Ab [Units/volume] in Serum

403

1.34

1.30

1.1

1.0

u/ml

0.2

3.2

1.16

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

816

0.77

1.29

1.1

u/ml

2.3

0.04

486

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

287

2549

1.14

1.28

1.5

—

(3019225) pH of Specimen

150

1768

0.84

1.28

2.4

2.8

—

(40768795) Lymph node Pathology biopsy report

205

0.54

1.27

1.1

1.2

—

(1761868) Lipid panel - Serum or Plasma

1164

12222

0.93

1.26

2.0

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

165

1409

1.18

1.25

1.4

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

287

1.40

1.23

1.0

1.1

u/l

1.0

0.13

100

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

204

1.47

1.22

1.4

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

503

4629

1.10

1.21

1.4

nmol/l

20.6

20.5

0.11

464

4186

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2837

27842

1.08

1.19

2.7

mmol/l

1.5

1.6

16.75

2718

26823

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

131

1103

1.19

1.18

1.5

2.0

u/l

36.7

38.7

0.87

123

1049

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

256

1.41

1.17

1.0

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

109

903

1.21

1.17

1.3

1.4

u/ml

4.5

6.7

0.30

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

440

0.70

1.17

1.9

2.2

ug/l

78.7

264.6

1.32

367

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

1.16

0.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

804

1.22

1.16

1.1

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

129

0.46

1.16

1.0

2.2

umol/l

26.7

28.0

—

122

(3023520) Reticulocytes [#/volume] in Blood

123

1035

1.19

1.13

1.9

2.3

e9/l

67.2

69.9

0.35

107

712

(3011648) Oxygen content in Venous blood

114

0.44

1.12

1.0

2.6

11.4

11.0

—

114

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2863

28130

1.07

1.11

2.8

mmol/l

2.9

2.8

0.62

2710

26915

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

593

1.25

1.09

1.1

115.2

115.5

0.04

534

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

416

1.30

1.09

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.87

1.07

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

110

922

1.20

1.07

1.3

1.4

u/ml

14.3

10.3

0.13

157

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

120

1016

1.19

1.05

1.3

u/ml

7.8

28.4

—

(44813793)

306

1.34

1.03

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

370

0.70

1.02

1.0

1.5

g/l

3.0

0.00

288

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2847

27999

1.07

1.01

2.7

mmol/l

4.7

0.93

2720

26998

(3000764) Benzodiazepines [Presence] in Urine

287

3169

0.90

1.00

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

211

2370

0.88

0.99

2.3

2.4

31.9

33.3

1.12

163

1849

(3038177) Helicobacter pylori Ab [Presence] in Serum

762

0.80

0.99

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.71

0.98

1.1

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

1369

14203

0.94

0.98

4.2

5.8

7.4

7.7

6.23

1314

13468

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.84

0.98

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

175

0.57

0.98

1.6

2.8

—

(3035880) pH of Pleural fluid

0.00

0.97

0.0

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

318

1.32

0.97

1.5

1.7

17.9

17.3

0.61

149

(3028300) Cannabinoids [Presence] in Urine

290

3193

0.90

0.97

2.0

—

(3027008) Opiates [Presence] in Urine

289

3181

0.90

0.96

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

116

1.55

0.96

1.1

1.8

—

(3023410) Appearance of Cerebral spinal fluid

352

0.71

0.94

1.1

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.72

0.92

1.1

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.14

0.91

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

268

2430

1.11

0.91

2.0

2.4

ng/l

395.5

317.3

0.23

206

1888

(3020874) Milk IgE Ab [Units/volume] in Serum

402

1.27

0.90

1.1

1.0

u/ml

0.5

2.3

0.99

108

(3051611) Lipemic interference index of Serum or Plasma

170

0.59

0.89

2.7

2.8

—

(3004616) Nuclear Ab [Presence] in Serum

376

1.28

0.89

1.3

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

101

0.49

0.89

1.0

—

(3001556) Androgen free Index in Serum or Plasma

103

0.48

0.89

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

211

1.38

0.88

3.0

2.9

nmol/l

2.7

2.4

0.24

200

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.79

0.87

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

176

1977

0.88

0.86

1.5

1.6

mg/l

3.0

3.7

1.05

109

1239

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

378

0.74

0.84

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

239

1.34

0.84

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

285

0.70

0.83

1.4

—

(3016879) Cocaine [Presence] in Urine

264

2891

0.91

0.82

2.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

249

0.68

0.82

1.6

1.5

—

(3006270) Folate [Moles/volume] in Blood

213

0.66

0.81

1.1

nmol/l

371.5

422.3

0.63

208

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

137

1203

1.14

0.81

1.5

1.4

u/l

18.0

17.7

0.05

120

1009

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

198

1.37

0.80

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

576

5437

1.07

0.79

2.5

ug/g

92.5

92.8

0.01

455

4219

(3045414) Leukocytes [Presence] in Urine

144

1271

1.14

0.79

1.8

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

128

1121

1.15

0.79

1.9

2.1

g/l

0.2

0.69

121

1072

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.5

—

17.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

174

1942

0.89

0.78

2.7

4.4

0.1

0.02

382

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

749

1.18

0.78

1.1

1.2

u/ml

255.4

256.0

0.01

491

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

851

1.17

0.78

1.3

u/ml

15.9

35.3

1.75

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

187

0.64

0.78

1.8

1.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.77

0.0

1.3

—

557.2

—

(3014271) Vancomycin [Susceptibility]

0.00

0.77

0.0

2.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

878

0.84

0.77

1.4

nmol/l

24.4

33.9

2.46

828

(3011288) Drugs identified in Urine by Screen method

199

2201

0.90

0.77

4.4

2.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

530

1.21

0.76

1.3

ug/g

336.0

325.9

0.14

244

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.52

0.75

1.1

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

173

0.63

0.75

1.1

2.0

umol/l

1.9

0.16

159

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

333

1.26

0.74

1.5

1.3

—

27.7

—

(3006504) Eosinophils/100 leukocytes in Blood

1369

14110

0.95

0.74

4.0

5.6

2.7

0.16

1300

13263

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

108

1.48

0.73

1.1

1.2

—

(3027944) Amphetamines [Presence] in Urine

290

3140

0.92

0.73

1.9

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.80

0.72

1.3

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

159

1.39

0.72

1.5

2.1

ug/l

22.9

167.3

0.63

152

(3010838) Calcium [Moles/time] in 24 hour Urine

1.52

0.72

1.8

1.4

—

5.7

—

(3042517) Benzodiazepines panel - Urine

1.52

0.72

1.3

2.7

—

(3030467) Casts [#/volume] in Urine by Automated count

589

6206

0.94

0.72

2.4

e6/l

0.2

1.90

507

4399

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

206

0.68

0.71

1.1

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.58

0.71

1.2

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

131

1160

1.13

0.71

1.9

2.1

g/l

1.1

0.14

124

1112

(3003740) Influenza virus B Ag [Presence] in Specimen

923

0.85

0.70

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.92

0.70

1.0

1.2

ng/l

42.8

82.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

922

0.85

0.70

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

105

1199

0.87

0.70

2.8

3.4

ug/l

4.0

41.7

0.57

761

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

0.77

0.69

1.0

1.5

g/l

7.0

7.1

0.17

298

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

375

0.77

0.68

1.0

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

375

0.77

0.68

1.0

1.5

g/l

4.2

3.6

1.25

273

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

227

0.70

0.68

1.3

1.2

—

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

640

1.18

0.67

1.1

1.2

u/ml

2.2

4.1

0.99

229

(3022145) Colonoscopy Study observation

244

2649

0.92

0.67

1.3

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.55

0.67

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.63

0.66

1.4

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.53

0.66

1.0

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

214

0.70

0.66

1.3

1.7

umol/l

22.2

25.4

0.17

200

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

305

0.75

0.65

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.57

0.65

1.4

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

277

1.27

0.65

2.1

2.7

umol/l

36.1

31.2

0.27

243

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

136

1217

1.12

0.64

1.3

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

129

1151

1.13

0.64

1.1

u/ml

3.8

2.1

0.36

290

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

247

0.73

0.64

1.6

1.4

—

(36304419) Bacteria [Presence] in Urine

606

6352

0.95

0.63

2.3

—

(1002224) Polysomnography panel

121

1357

0.89

0.63

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

280

0.75

0.62

1.3

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

188

0.69

0.62

1.4

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

235

1.28

0.61

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

536

1.18

0.60

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

481

1.19

0.60

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

2.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.54

0.59

1.4

1.2

—

(4015189)

0.00

0.59

0.0

3.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.56

0.58

1.0

1.4

—

1949.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

0.58

0.0

1.0

—

37.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

113

0.62

0.58

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

387

0.80

0.57

1.6

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

158

1.33

0.57

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

105

935

1.13

0.56

1.1

u/ml

5.9

6.2

0.07

388

(4094501)

319

0.78

0.56

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.62

0.55

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

143

1573

0.91

0.55

1.4

1.5

nmol/l

0.6

0.5

0.68

122

1330

(3034426) Prothrombin time (PT)

123

0.65

0.54

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.50

0.54

1.4

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

239

0.75

0.54

1.7

2.6

1.9

1.1

0.33

186

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

231

1.26

0.53

2.1

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.48

0.53

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.49

0.53

3.5

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.45

0.53

1.2

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

173

1881

0.92

0.53

2.7

4.1

0.4

0.5

0.15

308

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

694

1.14

0.52

1.3

u/ml

8.9

2.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

332

1.21

0.52

1.9

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

388

1.19

0.51

1.0

u/ml

0.7

0.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

896

8682

1.04

0.50

1.6

pmol/l

99.7

99.2

0.12

537

5024

(3017446) Testosterone [Moles/volume] in Serum or Plasma

893

0.88

0.50

1.2

1.3

nmol/l

1.2

1.6

3.02

747

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

390

1.18

0.49

1.3

2.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.56

0.49

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

119

1079

1.11

0.48

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

212

0.75

0.48

1.3

1.0

u/ml

12.8

6.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

335

1.20

0.48

1.2

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

141

1290

1.10

0.48

1.1

u/ml

3.3

1.2

0.96

506

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2232

22630

0.97

0.48

2.7

2.5

u/l

28.2

27.3

0.47

2144

21886

(3022217) INR in Platelet poor plasma by Coagulation assay

126

1381

0.91

0.47

6.7

7.5

inr

1.0

1.42

251

(3020650) Glucose [Presence] in Urine

102

1.37

0.47

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

146

1.30

0.47

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

346

1.19

0.46

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.62

0.45

1.0

ug/l

70.0

75.0

—

(4198724)

276

0.80

0.45

4.0

2.8

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

138

1.31

0.45

3.4

2.1

ug/l

0.7

1.2

1.65

131

(3000093) Morphology [Interpretation] in Blood Narrative

147

1.29

0.45

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

127

1162

1.10

0.44

1.1

u/ml

4.5

6.3

0.60

649

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.45

0.44

1.1

1.4

—

(3000012) Reticulocyte production index

1.45

0.44

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

152

0.72

0.44

1.1

1.8

—

(3017181) Myelocytes/100 leukocytes in Blood

188

2016

0.93

0.44

2.6

4.3

0.8

0.7

0.50

411

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

208

0.77

0.43

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.37

0.43

1.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

130

0.69

0.43

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

231

2456

0.94

0.43

2.0

2.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

119

1089

1.10

0.42

1.1

u/ml

0.4

1.1

2.75

464

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.64

0.42

1.7

1.5

u/l

8.7

11.1

—

(44806071)

1.38

0.41

1.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

0.00

0.41

0.0

1.3

—

2.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3025315) Body weight

0.00

0.41

0.0

2.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.00

0.41

0.0

1.3

—

33.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.0

—

113.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.40

0.0

2.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.1

—

2.2

—

(40768443) Skin Pathology biopsy report

1003

0.90

0.40

1.1

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

508

0.86

0.40

1.6

g/l

0.6

0.7

0.14

390

(3037756) Immunofixation for Serum or Plasma

123

1.30

0.40

1.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.47

0.40

1.0

1.3

—

(3044007) Cell count panel - Peritoneal fluid

0.00

0.40

0.0

2.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

432

0.86

0.39

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1721

16939

1.03

0.39

5.6

8.0

e9/l

4.2

4.0

5.08

1617

15076

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.39

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

233

1.20

0.38

1.8

2.6

—

(3016750) Collection duration of Urine

1.36

0.38

1.6

2.5

min

488.4

511.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

148

1589

0.93

0.37

1.6

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

107

1.31

0.37

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

169

0.77

0.37

1.3

1.2

u/l

7.3

23.9

1.35

144

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

134

1.27

0.36

2.6

3.1

49.0

45.8

—

(42870588) Differential panel, method unspecified - Blood

932

9098

1.03

0.36

4.0

5.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.29

0.36

1.1

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.29

0.36

1.1

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.27

0.36

1.1

2.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

763

7429

1.03

0.35

2.1

2.7

mmol/l

2.3

3.18

699

6759

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

122

0.74

0.35

1.1

u/ml

0.7

0.8

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

124

0.73

0.35

1.0

mg/g

4.1

4.6

—

119

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

168

1577

1.07

0.35

2.4

2.3

g/l

0.2

1.09

161

1491

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

126

0.71

0.35

1.7

2.7

—

(3011412) CD3 cells [#/volume] in Blood

311

1.16

0.34

1.7

2.8

e9/l

1.3

0.04

180

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

311

1.16

0.34

2.3

1.9

nmol/l

20.7

21.7

0.29

296

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.33

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

453

1.13

0.33

1.5

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

155

0.77

0.33

1.9

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.69

0.33

1.2

u/l

51.2

83.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.67

0.33

1.3

2.5

—

118.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

338

0.86

0.32

1.0

1.5

g/l

10.7

10.6

0.02

294

(40760888) Immunoglobulin light chains.free panel - Serum

137

1.24

0.32

1.2

2.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

211

2003

1.06

0.32

3.5

5.1

mmol/l

1.0

0.15

201

1883

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

119

1109

1.08

0.31

1.4

1.6

iu/ml

2.5

0.4

0.39

203

(3000475) Leukocytes [#/volume] in Synovial fluid

333

1.14

0.31

1.6

1.7

e6/l

3744.8

6148.0

0.91

245

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

296

1.15

0.30

1.4

—

(3001604) Monocytes [#/volume] in Blood

1512

14907

1.02

0.29

4.1

5.6

e9/l

0.5

2.55

1419

13377

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

628

0.91

0.28

1.1

1.2

u/ml

3.8

4.6

0.30

252

(3014133) Dog dander IgE Ab [Units/volume] in Serum

108

1009

1.07

0.28

1.1

u/ml

7.5

5.5

0.32

391

(3006315) Basophils [#/volume] in Blood

1516

14957

1.02

0.27

4.1

5.7

e9/l

0.0

0.21

1422

13377

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.25

0.27

1.3

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

150

0.80

0.27

2.3

2.5

—

(3013115) Eosinophils [#/volume] in Blood

1573

15532

1.02

0.26

4.1

5.9

e9/l

0.2

0.44

1483

14082

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

998

0.93

0.26

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

286

2753

1.04

0.26

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

122

1148

1.06

0.26

2.5

3.4

ng/l

67.6

71.5

0.23

110

1051

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

168

1597

1.05

0.26

3.3

2.1

ml/min/173m2

82.1

87.0

0.60

588

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.25

0.25

2.1

2.3

—

(3025159) Blasts/100 leukocytes in Blood

180

1887

0.95

0.25

2.7

4.4

0.0

0.3

0.59

333

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

207

1.16

0.25

8.0

8.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

159

0.82

0.24

1.1

—

(4133840)

0.71

0.24

1.0

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.71

0.24

1.2

u/l

6.0

21.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

275

2849

0.96

0.23

1.3

miu/ml

217.6

243.2

0.70

136

1503

(3007916) DNA double strand Ab [Titer] in Serum

1.28

0.23

1.0

1.2

—

227.7

—

(3007463) Buprenorphine [Presence] in Urine

1.28

0.23

2.8

7.7

—

(3018418) pH of Serum or Plasma

589

5762

1.03

0.22

2.9

3.2

7.4

0.02

116

1066

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

163

1.17

0.21

2.1

2.2

mg/l

9.1

10.0

0.30

130

(3052592) Norovirus Ag [Presence] in Stool

1.19

0.21

1.0

1.3

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

33.5

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

8.1

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

20.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

4.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.0

—

9.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

30.3

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

103

0.78

0.21

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

0.00

0.21

0.0

1.2

—

3.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.5

—

38.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

3.2

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.20

0.0

1.4

—

2007.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

233

2252

1.04

0.20

1.2

1.1

titre

597.0

178.4

—

(3042631) Mycobacterium sp identified in Specimen

114

0.79

0.20

1.4

2.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

644

0.93

0.19

1.1

1.6

—

(3026782) Osmolality of Urine

419

4290

0.97

0.19

2.4

2.3

mosm/kgh2o

550.4

530.1

0.84

381

3589

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

291

0.89

0.19

1.2

u/ml

0.0

0.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

238

0.88

0.18

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.17

0.17

1.0

1.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

116

1213

0.95

0.17

1.3

1.4

pmol/l

46.1

58.0

1.82

111

1175

(21494890) Protein electrophoresis panel - 24 hour Urine

1.13

0.17

1.0

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.22

0.17

1.0

1.1

—

(3024471) HLA-A [Type]

0.76

0.17

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

129

1.16

0.17

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

236

0.89

0.16

1.0

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.16

0.16

1.4

1.2

nmol/l

97.8

85.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

194

2003

0.97

0.16

1.3

u/l

10.2

9.8

0.14

176

1662

(3000494) Fungus identified in Specimen by Culture

303

2956

1.03

0.16

1.5

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

674

6838

0.98

0.15

2.6

2.5

e6/l

29.0

74.5

2.02

552

4939

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

255

0.90

0.15

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

213

0.89

0.15

1.7

3.2

e6/l

734.6

876.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.10

0.15

1.2

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

265

1.10

0.14

3.6

4.1

u/ml

0.4

0.00

133

(3017354) Segmented neutrophils/100 leukocytes in Blood

150

0.87

0.14

1.8

2.2

56.0

53.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

169

1.12

0.14

1.3

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

217

1.11

0.14

2.2

1.7

mg/l

21.9

24.5

0.14

(44816559) Phosphatidylethanol [Mass/volume] in Blood

733

1.05

0.14

1.2

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

254

0.90

0.14

1.6

2.4

40.8

47.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

285

1.09

0.14

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

285

1.09

0.14

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

285

1.09

0.14

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

0.82

0.13

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

480

1.06

0.13

1.3

1.2

nmol/l

61.1

57.0

0.17

475

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2677

26666

1.01

0.13

2.5

mmol/l

1.1

2.65

2568

25697

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

500

1.06

0.13

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

257

1.09

0.13

1.7

2.4

11.8

12.1

0.07

152

(3045683) HLA typing for celiac disease panel - Blood or Tissue

366

0.93

0.13

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

277

1.08

0.12

1.0

—

(3049717) Cytology report of Urine Cyto stain

262

0.92

0.12

1.3

1.7

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

104

1.15

0.12

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

104

1.15

0.12

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

104

1.15

0.12

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

147

0.88

0.11

2.5

2.1

umol/l

11.1

15.5

1.47

147

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

126

0.87

0.11

1.2

1.1

—

(4062490)

353

0.93

0.11

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

182

1.10

0.11

1.5

1.9

50.4

46.5

0.15

115

(3024522) Salmonella sp identified in Specimen by Organism specific culture

290

1.07

0.10

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

606

0.96

0.10

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

351

0.94

0.10

1.5

g/l

3.0

0.07

251

(3024139) IgG subclass 3 [Mass/volume] in Serum

351

0.94

0.10

1.5

g/l

0.4

0.15

252

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

291

1.07

0.09

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

625

0.96

0.09

2.4

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

155

1.10

0.09

4.2

3.7

u/ml

61.2

35.7

0.21

141

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.13

0.09

1.5

3.6

—

(3002619) Bacteria identified in Specimen by Culture

1.09

0.08

1.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

247

0.93

0.08

1.1

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

206

0.92

0.08

1.0

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

1578

15706

1.01

0.08

4.1

5.5

e9/l

2.0

0.07

1478

14334

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.82

0.08

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.14

0.08

1.1

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.14

0.08

1.1

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.14

0.08

1.1

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.14

0.08

1.1

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

1017

0.97

0.08

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

956

0.97

0.08

2.0

2.3

140.4

156.8

1.23

888

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

133

0.90

0.07

2.0

1.8

—

148.8

—

(3024263) Appearance of Synovial fluid

0.84

0.07

1.7

2.5

—

(3021901) Oxygen saturation in Capillary blood

225

1.07

0.07

2.2

1.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.05

0.07

1.5

1.6

ug/l

8.3

7.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.04

0.07

1.9

1.6

—

(3028433) Virus identified in Specimen by Culture

1.04

0.07

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

164

1610

1.02

0.07

2.3

1.6

0.05

147

1406

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

102

996

1.02

0.07

1.4

2.1

101.3

94.7

2.77

900

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

802

0.97

0.07

1.1

1.0

u/ml

0.2

0.4

0.57

157

(3012544) pH of Venous blood

129

1264

1.02

0.07

2.2

3.3

—

7.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.02

0.07

1.7

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

226

1.06

0.06

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

433

1.04

0.06

4.8

4.6

u/ml

79.8

94.5

—

159

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.11

0.06

1.0

1.1

78.2

66.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

142

0.92

0.06

1.2

3.5

umol/l

53.8

167.6

—

(4268621)

444

1.04

0.06

1.8

2.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

557

0.97

0.05

1.5

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

178

1.07

0.05

1.2

1.3

g/l

0.3

0.34

146

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

789

0.98

0.05

1.8

2.4

kpa

4.9

5.1

1.56

751

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.11

0.05

1.1

1.0

—

(3036489) Thrombin time

115

1129

1.02

0.05

1.3

2.0

19.7

20.4

1.27

919

(3002032) Base excess in Venous blood by calculation

125

1229

1.02

0.05

2.2

3.4

mmol/l

1.8

1.6

0.36

958

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

693

1.03

0.05

1.7

titre

193.3

372.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

222

0.95

0.05

1.6

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

317

1.04

0.05

1.9

2.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

191

0.94

0.04

1.1

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1007

0.98

0.04

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

200

0.95

0.03

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1131

11277

1.00

0.03

2.1

—

(3009343) pH of Capillary blood

784

0.98

0.03

1.8

2.4

7.4

0.64

119

(3027135) IgG subclass 1 [Mass/volume] in Serum

351

0.97

0.03

1.5

g/l

5.4

6.6

1.71

253

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

108

0.93

0.03

1.6

mg/l

3.9

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

100

1012

0.99

0.02

1.2

1.1

—

(3022313) Gas panel - Capillary blood

510

0.98

0.02

1.9

2.5

—

(3016018) Differential panel - Cerebral spinal fluid

339

0.97

0.02

1.1

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

912

9138

1.00

0.02

1.9

1.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

107

0.93

0.02

1.3

2.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

639

0.99

0.01

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

929

0.99

0.01

2.0

1.9

g/l

67.3

68.1

0.45

867

(3047007) Chlamydophila sp Ab [Presence] in Serum

663

1.01

0.01

1.2

—

(3016228) CD19 cells/100 cells in Blood

106

0.94

0.01

1.3

2.6

9.9

8.4

—

106

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

1.04

0.00

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

240

2407

1.00

0.00

2.1

u/ml

24.0

32.5

1.97

227

2329

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

726

0.99

0.00

1.2

1.1

au/ml

30.6

11.0

—

(4211845)

162

0.99

0.00

3.1

1.9

—

(3006462) Nitrate [Presence] in Urine

145

0.97

0.00

3.1

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

762

1.00

0.00

1.8

2.3

mmol/l

0.6

0.9

0.45

502

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

139

1.01

0.00

1.6

1.8

u/field

9.3

2.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

189

1.01

0.00

1.3

2.4

mg/l

37.5

29.9

0.15

160

(3006442) Creatine [Moles/volume] in Serum or Plasma

189

1.01

0.00

1.2

umol/l

61.8

64.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

189

1.01

0.00

1.3

2.4

mg/l

15.4

22.7

2.62

158

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

261

1.00

0.00

1.2

1.1

iu/ml

11.8

6.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

104

0.96

0.00

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

156

1.03

0.00

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

124

0.97

0.00

1.5

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

288

2877

1.00

0.00

2.5

2.9

mmol/l

0.8

0.81

274

2691

(3013139) Helicobacter pylori Ag [Presence] in Stool

219

2187

1.00

0.00

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

147

1.02

0.00

1.3

2.7

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

2.9

—

(3001729) Color of Synovial fluid

0.00

0.0

1.4

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

12.3

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.4

—

655.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

10.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.8

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.93

0.00

1.9

5.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

3.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

0.0

1.1

—

11.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.95

0.00

1.9

1.6

umol/l

17.3

17.7

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.91

0.00

1.8

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.88

0.00

1.6

2.7

ug/l

10.5

24.5

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.0

3.0

—

0.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

2.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.93

0.00

1.8

3.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.0

4.6

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

225.9

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

130

1.00

0.00

1.8

2.4

e6/l

295.0

183.2

—

(3016038) Potassium [Moles/volume] in Urine

0.89

0.00

1.1

1.7

mmol/l

58.3

38.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.91

0.00

1.8

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.00

0.00

1.6

3.9

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint O15_ANTENAT_ABNORM and mortality.

Females

Parameter	HR [95% CI]	p-value
O15_ANTENAT_ABNORM	0.66 [0.53, 0.83]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.022

During the follow-up period (1.1.1998 — 31.12.2019), 105 out of 22922 females with O15_ANTENAT_ABNORM died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_ANTENAT_ABNORM.

N-year risk	Females	Males
1	0.042%	No data
5	0.303%	No data
10	0.824%	No data
15	1.62%	No data
20	2.839%	No data

Relationships between endpoints

↥

Index endpoint: O15_ANTENAT_ABNORM – Abnormal findings on antenatal screening of mother

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Abnormal findings on antenatal screening of mother

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints